Which companies will be added to the S&P 500 in Q3?
$0.00
1
22
Which companies will be added to the S&P 500 in Q3?
$0.00
1
22
AI Analysis
Trader mode: Actionable analysis for identifying opportunities and edge
About This Event
Q3 2026 If X is announced to be or is officially added to S&P 500 during July 1, 2026 to September 30, 2026, then the market resolves to Yes. The market resolves to Yes if either the index administrator officially announces the membership change OR the change takes effect during the specified time period, whichever occurs first. The effective date of the change need not fall within the time period; only the announcement or implementation must occur within the time period. Temporary suspensions
What Prediction Markets Are Forecasting
Traders on Kalshi see roughly a 1 in 4 chance that Alnylam Pharmaceuticals will join the S&P 500 during the third quarter of 2026. That 28% probability means the market thinks this is unlikely but far from impossible. For comparison, most stocks that are seriously discussed as potential S&P 500 additions trade at probabilities above 50% when their addition is imminent.
Why the Market Sees It This Way
Alnylam is a biotech company that specializes in RNA interference drugs, a technology for silencing disease-causing genes. The company has several approved products and a market capitalization around $30 billion, which would normally make it a candidate for the index.
Three factors explain the low probability. First, S&P 500 additions are heavily weighted toward profitability. Alnylam has been losing money, though it recently reported its first profitable quarter. Second, the index committee makes decisions behind closed doors with no public schedule. Companies can meet all the criteria for months or years before being added. Third, there is a long list of larger, more profitable companies that are ahead in line. Companies like Uber, Palantir, and Coinbase all have market caps above Alnylam and clearer paths to inclusion.
Key Dates and Events to Watch
The most important signal would be Alnylam reporting sustained profitability. If the company posts two or three consecutive profitable quarters, the probability would likely jump. Quarterly earnings announcements are the main events to track.
The S&P 500 committee typically announces changes on a Friday after markets close, with the change taking effect the following week. There is no fixed calendar, but the committee tends to make changes when there is a clear reason, such as a company being acquired or going bankrupt and needing replacement.
How Reliable Are These Predictions
Prediction markets have mixed accuracy for S&P 500 additions. The committee's decision process is genuinely opaque, which makes forecasting harder than for events with clear rules like elections or sports outcomes. Markets are good at ruling out obvious candidates that won't be added. But they often miss the timing when a company does get added, because the committee can act suddenly. For a stock trading at 28% odds, the market is telling you the company is a plausible candidate but probably not the next one in line.
Current Market Outlook
Kalshi traders give Alnylam Pharmaceuticals a 28% chance of joining the S&P 500 in Q3 2026. That is a low probability, meaning the market sees this as a real possibility but not the base case. A 28% price implies roughly 3.6-to-1 odds against inclusion, which aligns with the reality that only a handful of companies get added each quarter despite hundreds being eligible.
The market is pricing Alnylam as the leading candidate among possible additions, but 28% is still a long way from a coin flip. For context, when a company is widely expected to be added, markets typically price above 60% in the weeks before the announcement.
Key Factors Driving the Odds
Alnylam meets the basic S&P 500 eligibility criteria: it has a market cap above $20 billion (currently around $35 billion), positive GAAP earnings over the trailing four quarters, and sufficient liquidity. The company became profitable in 2024 after years of R&D spending on its RNAi therapeutic platform, and its revenue growth from drugs like Amvuttra and Onpattro has been steady.
The main factor keeping odds at 28% is timing. The S&P 500 index committee does not follow a fixed schedule for additions, and replacements typically happen only when an existing constituent is acquired or goes bankrupt. In Q3 2026, the committee will likely add 2-4 companies, but there are dozens of qualified candidates. Alnylam faces competition from other profitable mid-cap biotechs and tech firms with similar market caps.
Another factor: the index committee has historically been conservative about adding biotech companies without diversified revenue streams. Alnylam's dependence on a small number of drugs could be a concern, even though the drugs are approved and growing.
What Could Change These Odds
The biggest catalyst would be a major acquisition announcement of an existing S&P 500 company in the healthcare or biotech sector. That would create a vacancy the committee needs to fill, and Alnylam would be a natural candidate. If no vacancies open up in Q3, Alnylam's odds drop to near zero regardless of its fundamentals.
Earnings reports in late July 2026 could also move the odds. If Alnylam reports better-than-expected revenue or raises guidance, the market could push odds above 40%. A disappointing quarter would likely drop them below 15%.
The committee's quarterly rebalancing announcements (typically in early September) are the specific dates to watch. If Alnylam is not added by mid-September, the odds will collapse as the window closes.
AI-generated analysis based on market data. Not financial advice.
Overview
The S&P 500 is a stock market index that tracks the performance of 500 large-cap companies listed on U.S. exchanges. It is widely regarded as the best single gauge of large-cap U.S. equities. The index is maintained by S&P Dow Jones Indices, a division of S&P Global. Companies are added to the index based on specific criteria including market capitalization, liquidity, domicile, public float, sector classification, and financial viability. The index committee meets quarterly to review and make changes. This prediction market focuses on which companies will be added to the S&P 500 during the third quarter of 2026, from July 1 to September 30, 2026. Companies are typically added to the S&P 500 when they meet the eligibility criteria and when there is a vacancy created by a merger, acquisition, or a company being removed for failing to meet criteria. The most common reason for removal is a merger or acquisition. Less frequently, a company may be removed due to bankruptcy, restructuring, or falling below the market capitalization threshold. The index committee, led by managing directors at S&P Dow Jones Indices, makes the final decisions. The committee considers not just quantitative criteria but also qualitative factors like sector representation and index continuity. In recent years, the S&P 500 has seen a steady stream of additions as the U.S. economy evolves. Technology and healthcare companies have been particularly active in joining the index. The pace of additions has accelerated in some years due to a wave of IPOs and SPAC mergers. For example, in 2021, a record number of companies were added as many high-growth companies went public. In 2023 and 2024, the pace moderated but remained active. Investors pay close attention to these changes because index funds tracking the S&P 500 must buy shares of newly added companies, often driving up their stock price temporarily. The prediction market for Q3 2026 additions attracts interest from traders and investors who follow corporate events, earnings reports, and market capitalization trends. The market resolves to Yes if either the announcement or the effective date of the addition falls within the July-September 2026 window. This means a company announced in late September for an October effective date would still count. The market is binary: it pays out if at least one company is added during that period. However, the wording 'which companies' implies a list, but the description indicates a single Yes/No resolution for any addition.
Historical Context
The S&P 500 was introduced in 1957 by Standard & Poor's (now S&P Global). It replaced the earlier S&P 90 index, which had tracked 90 stocks since 1926. The index started with 500 companies and has maintained that count, though the exact number can vary slightly due to timing of additions and removals. The methodology has evolved over time. For example, in 2005, S&P introduced a requirement that companies have positive as-reported earnings over the most recent four quarters. In 2017, the market capitalization requirement was raised from $4.0 billion to $6.1 billion, with annual adjustments for inflation. As of 2025, the requirement is approximately $15.8 billion. Historically, the index has seen waves of additions during periods of economic expansion and IPO booms. In 1999, during the dot-com bubble, many technology companies were added, only to be removed later when their stock prices crashed. In 2008-2009, during the financial crisis, several financial companies were removed due to bankruptcy or government bailouts. In 2020-2021, a record number of companies were added as SPAC mergers and direct listings brought many new public companies to market. For example, in 2021 alone, 54 companies were added, including many from the technology and healthcare sectors. Notable additions include Amazon (2005), Google (2006), and Tesla (2020). Each of these additions reflected the company's growth in market capitalization and eligibility. Tesla's addition was notable because it was one of the largest market cap companies ever added at the time, and it came after years of speculation. The index committee has also removed companies like Enron (2001, after bankruptcy) and General Electric (2018, after years of decline). GE's removal was historic because it was one of the original 12 companies in the Dow Jones Industrial Average and had been in the S&P 500 since 1896.
Why It Matters
The addition of a company to the S&P 500 has significant financial implications. Index funds that track the S&P 500, such as those from Vanguard, BlackRock, and State Street, collectively manage trillions of dollars in assets. When a company is added, these funds must buy its shares, often in large quantities. This buying pressure can push the stock price up by 3-5% on average in the days around the announcement and effective date. Conversely, removal can lead to selling pressure. For the company, being added to the S&P 500 provides increased visibility, credibility, and liquidity. It can also attract more analyst coverage and institutional investment. For investors, understanding which companies might be added is a trading opportunity. Some investors try to front-run the addition by buying shares of likely candidates before the announcement. Others wait for the announcement and trade on the price movement. The prediction market allows traders to speculate on the outcome. For the broader market, changes to the S&P 500 composition reflect the evolving structure of the U.S. economy. Sectors that are growing, like technology and healthcare, tend to gain representation. Sectors that are shrinking, like energy and materials, tend to lose representation. This makes the index a dynamic reflection of economic trends.
Educational content is AI-generated and sourced from Wikipedia. It should not be considered financial advice.
